Cell Therapeutics, Inc. (NASDAQ:CTIC) will unveil its latest earnings on Tuesday, July 26, 2011. Cell Therapeutics, Inc. develops, acquires and commercializes novel treatments for cancer.
Cell Therapeutics, Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for a loss of 12 cents per share, a narrower loss from the year earlier quarter net loss of 48 cents. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged and it has not changed during the last month.
Past Earnings Performance: The company is looking to break the streak of missing estimates in the past two quarters. Last quarter, it fell short of analyst expectations by reporting net loss of 36 cents per share against an estimate of a loss of 12 cents per share. The quarter before that, it missed forecasts by 12 cents.
Competitors to Watch: Celgene Corporation (NASDAQ:CELG), Novartis AG (NYSE:NVS), Telik, Inc. (NASDAQ:TELK), Eli Lilly & Co. (NYSE:LLY), Pfizer Inc. (NYSE:PFE), Bristol Myers Squibb Co. (NYSE:BMY), SuperGen, Inc. (NASDAQ:SUPG), ArQule, Inc. (NASDAQ:ARQL).
Stock Price Performance: During April 25, 2011 to July 20, 2011, the stock price had fallen 93 cents (-40.8%) from $2.28 to $1.35. The stock price saw one of its best stretches over the last year between September 17, 2010 and September 23, 2010 when shares rose for five-straight days, rising 11.4% (+24 cents) over that span. It saw one of its worst periods between July 1, 2011 and July 12, 2011 when shares fell for seven-straight days, falling 16.8% (-28 cents) over that span. Shares are down 87 cents (-39.2%) year to date.
(Source: Xignite Financials)
Get Actionable Investing Insights: Check Out Wall St. Cheat Sheet’s newest Feature Trades of the Month!